I agree that this site is using cookies. You can find further informations here.
X
Bottomly, Daniel
86  results:
Search for persons X
?
1

Upregulation of HOXA3 by isoform‐specific Wilms tumour 1 dr..:

Allen, Basil ; Savoy, Lindsey ; Ryabinin, Peter...
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resis..:

Modak, Rucha V. ; de Oliveira Rebola, Katia G. ; McClatchy, John...
Clinical Cancer Research.  30 (2024)  10 - p. 2245-2259 , 2024
Link: https://doi.org/10.1158/..
 
?
3

Just how transformative will AI/ML be for immuno-oncology?:

Bottomly, Daniel ; McWeeney, Shannon
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e007841 , 2024
Link: https://doi.org/10.1136/..
 
?
4

Immune cell proportions correlate with clinicogenomic featu..:

Romine, Kyle A. ; Bottomly, Daniel ; Yashar, William...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

Comparison and validation of the 2022 European LeukemiaNet ..:

Lachowiez, Curtis A. ; Long, Nicola ; Saultz, Jennifer...
Blood Advances.  7 (2023)  9 - p. 1899-1909 , 2023
Link: https://doi.org/10.1182/..
 
?
6

Associating drug sensitivity with differentiation status id..:

Kurtz, Stephen E. ; Eide, Christopher A. ; Kaempf, Andy...
Blood Advances.  6 (2022)  10 - p. 3062-3067 , 2022
Link: https://doi.org/10.1182/..
 
?
7

Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Op..:

Rice, William G. ; Howell, Stephen B. ; Zhang, Hongying...
Molecular Cancer Therapeutics.  21 (2022)  7 - p. 1125-1135 , 2022
Link: https://doi.org/10.1158/..
 
?
8

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B..:

Thieme, Elana ; Liu, Tingting ; Bruss, Nur...
Cell Death & Disease.  13 (2022)  3 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
9

Secondary fusion proteins as a mechanism of BCR::ABL1 kinas..:

Barnes, Evan J. ; Eide, Christopher A. ; Kaempf, Andy...
British Journal of Haematology.  200 (2022)  3 - p. 323-328 , 2022
Link: https://doi.org/10.1111/..
 
?
10

Integrative analysis of drug response and clinical outcome ..:

Bottomly, Daniel ; Long, Nicola ; Schultz, Anna Reister...
Cancer Cell.  40 (2022)  8 - p. 850-864.e9 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Functional proteomics of patient derived head and neck squa..:

Vigoda, Myles ; Mathieson, Chase ; Evans, Nathaniel...
Cancer Biology & Therapy.  23 (2022)  1 - p. 309-317 , 2022
Link: https://doi.org/10.1080/..
 
?
12

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutat..:

Yenerall, Paul ; Kollipara, Rahul K. ; Avila, Kimberley...
Cancer Research.  81 (2021)  18 - p. 4685-4695 , 2021
Link: https://doi.org/10.1158/..
 
?
13

The AML microenvironment catalyzes a stepwise evolution to ..:

Joshi, Sunil K. ; Nechiporuk, Tamilla ; Bottomly, Daniel...
Cancer Cell.  39 (2021)  7 - p. 999-1014.e8 , 2021
Link: https://doi.org/10.1016/..
 
?
14

A noncanonical FLT3 gatekeeper mutation disrupts gilteritin..:

Joshi, Sunil K. ; Sharzehi, Setareh ; Pittsenbarger, Janét...
American Journal of Hematology.  96 (2021)  7 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
15

ERBB2/HER2 mutations are transforming and therapeutically t..:

Joshi, Sunil K. ; Keck, Jamie M. ; Eide, Christopher A....
Leukemia.  34 (2020)  10 - p. 2798-2804 , 2020
Link: https://doi.org/10.1038/..
 
1-15